To understand how microarray technology is evolving to meet growing scientific demands, Technology Networks spoke with Thermo ...

A single microarray can provide information on the expression of tens of thousands of genes. The amount of information generated by a microarray-based experiment is sufficiently large that no single ...

The Global MiRNA Microarray Kits And Reagents Market is projected to grow at a CAGR of 8.5% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals that ...

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance ...

New studies reveal that optical genome mapping (OGM) can detect chromosomal abnormalities linked to recurrent pregnancy loss, ...

The data, which is being presented at this year's AMP meeting, offers some insights into the often hidden causes of recurrent pregnancy loss.

Revenue Guidance -- Management reiterated full-year fiscal 2025 revenue guidance of $26 million to $30 million and set Q4 fiscal 2025 outlook to $7.5 million to $7.9 million.

The global biochips market, valued at US$12.97 billion in 2024, stood at US$14.01 billion in 2025 and is projected to advance at a resilient ...

Bionano Genomics, Inc. (NASDAQ: BNGO) Q3 2025 Earnings Call Transcript November 13, 2025 Bionano Genomics, Inc. beats earnings expectations. Reported EPS is $-1.59292, expectations were $-1.81.

Pregnancy loss may occur in as many as 25% of all pregnancies. Most of these losses occur in the first trimester, and about half are caused by genetic or chromosomal issues.

Pregnancy loss affects up to 25% of pregnancies. New studies using optical genome mapping reveal genetic and fragile-site ...